Nanomedicine and Neuroprotection in Brain Diseases

Erscheinungsjahr 2021
ISBN: 978-0-323-90162-8
Verlag: William Andrew Publishing

Buch, Englisch, 442 Seiten, Format (B × H): 152 mm x 229 mm, Gewicht: 1100 g

Progress in Brain Research series, highlights new advances in the field, with this new volume presenting interesting chapters. Each chapter is written by an international board of authors.

Zielgruppe

<p>Undergraduates, graduates, academics, and researchers in the field of neurology and brain research </p>

Autoren/Hrsg.

Sharma, Aruna

Fachgebiete

• Interdisziplinäres Wissenschaften Wissenschaften Interdisziplinär Neurowissenschaften, Kognitionswissenschaft
• Sozialwissenschaften Psychologie Allgemeine Psychologie Biologische Psychologie, Neuropsychologie

Inhaltsverzeichnis

1. Alzheimer's disease neuropathology is exacerbated following traumatic brain injury. Neuroprotection by co-administration of nanowired mesenchymal stem cells and cerebrolysin with monoclonal antibodies to amyloid beta protein
2. Glioblastoma: what can we do for these patients today and what will we be able to do in the future?
3. Network Pharmacological Mechanism of Cinobufotalin against Glioma
4. Nanodelivery of Oxiracetam enhances memory, functional recovery and induces neuroprotection following concussive head injury
5. Clinical neurorestorative cell therapies for stroke
6. Nanodelivery of traditional Chinese Gingko Biloba extract EGb-761 and bilobalide BN-52021 induces superior neuroprotective effects on pathophysiology of heat stroke
7. Upregulation of hemeoxygenase enzymes HO-1 and HO-2 following ischemia-reperfusion injury in connection with experimental cardiac arrest and cardiopulmonary resuscitation: Neuroprotective effects of methylene blue
8. Multimodal imaging in the differential diagnosis of glioma recurrence from treatment-related effects: a systematic review and network meta-analysis. A protocol for systematic review and network metaanalysis
9. Manganese nanoparticles induce blood-brain barrier disruption, cerebral blood flow reduction, edema formation and brain pathology associated with cognitive and motor dysfunctions
10. Targeted Therapy with Anlotinib for a Leptomeningeal Spread Recurrent Glioblastoma Patient

Über Autor(innen)

Sharma, Aruna
Aruna Sharma, MD is currently Secretary of Research at Uppsala University Hospital, Uppsala University, Sweden. She obtained her Bachelor of Science in 1971 and trained in Indian Medicine up to 1977 and engaged in medical research from 1978 to 1986 in India on hyperthermia induced brain dysfunction in the lab of Hari Sharma and Prasanta Kumar Dey under University Grants Commission and Indian Council of Medical Research

Her main interest is now focused on Indian Medicinal drugs and their effects on the Central Nervous System Function, toxicology, neurorepair and neuroprotection. She is also investigating neurotoxicological profiles of many Ayurvedic traditional drugs with special reference to those containing metal oxide or metal ashes.